THERAPiN

Cannabis-based Drug Preparations

Health Tech & Life Sciences
Active
Series A Ramot Menashe, Israel Founded 2017
Website ↗ LinkedIn
Last updated 2026-06-18
Total raised
$22.0M
Last: 2020-04
Stage
Series A
Founded
2017
Headcount
8
HQ
Ramot Menashe, Israel
Sector
Health Tech & Life Sciences

About

THERAPiN develops, grows, and produces raw materials and premium cannabis products for medical and cosmetic use for the international market.

Funding history · 2 rounds · $22.0M total

2020-04
2019-12

Q&A

What is THERAPiN's primary business?
THERAPiN develops, grows, and produces raw materials and premium cannabis products for medical and cosmetic use for the international market.
When was THERAPiN founded?
THERAPiN was founded in September 2017.
What is the total amount of funding THERAPiN has raised to date?
THERAPiN has raised a total of $22,000,000 USD.
When was THERAPiN's most recent funding round?
THERAPiN's most recent funding round occurred in April 2020.
What is THERAPiN's primary sector?
THERAPiN's primary sector is Health Tech & Life Sciences.
What types of customers does THERAPiN target?
THERAPiN targets customers in Healthcare & Life Sciences, Pharmaceuticals, Cosmetics, Consumers, Recreational & Lifestyle, and Cannabis.
What business models does THERAPiN operate under?
THERAPiN operates under B2C and B2B business models.

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyMedical Cannabis
Technologies
BiologicalsHerbalsMaterials & SubstancesRaw Materials
Target customers
Healthcare & Life SciencesLife SciencesPharmaceuticalsCosmeticsConsumersRecreational & LifestyleCannabis
Business model
B2CB2B

Tags

pharmaceuticalsmedical-cannabismedical-productspatientsconsumerspharma-companieschronic-patients
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)